GnRH agonist analog; D-Ser(tBu)6 and Azgly10 modifications enhance stability. Long-acting implant formulation, administered once monthly or every 3 months. Used for prostate cancer, breast cancer, and endometriosis. Research-grade material for studies of GnRH receptors, long-acting formulations, and endocrine therapy.
Basic Information
- Product Name
- Goserelin
- Catalog No.
- P-32042
- CAS No.
- —
- Sequence
- [Pyr]HWSY[dS](tBu)LRP[azG]-NH2
- Molecular Formula
- C49H68N14O12
- Molecular Weight
- 1559.75
Peptide Depictor
10 aa
Mouse wheel or pinch to zoom, drag to pan, click to show residue structure
Natural AA
Non-natural AA
Linker-like
Side-chain mod
Unknown
Acidic
Basic
Hydrophobic
Aromatic
Modified
Disulfide bond
Cyclization bond
AI-Assisted Peptide Property AnalysisShowHide
Sequence Overview
[Pyr]HWSY[dS](tBu)LRP[azG]-NH2
Length
10.00
Molecular Weight
1268.64 Da
Monoisotopic Mass
1268.64 Da
Estimated Net Charge
1.100
pI
11.36
Hydrophobicity GRAVY
-0.8500
Physicochemical Properties
Basic Residue Ratio
10%
Acidic Residue Ratio
0%
Aromatic Residue Ratio
20%
Cys Count
0.000
Oxidation-Risk Residues
1.000
Asp-Gly / Asn-Gly
0.000
Solubility Analysis
Water Solubility
Good
Acidic Aqueous Compatibility
Suitable
Basic Aqueous Compatibility
Use with caution
DMSO Solubility Tendency
Moderate
Recommended Delivery Form
free
- 未发现明显溶解性风险
Calculation Parameters
Calculated parameters are model predictions for research design, candidate comparison, and project evaluation only. They are not experimental measurements or final synthesis outcomes.
| Property | Parameter | Value | Result |
|---|---|---|---|
| Hemolysis Risk | score threshold | 0.1817————0.5640 | Non-hemolytic |
| Non-Fouling | score threshold | 0.01524————0.3892 | Fouling |
| Solubility | score threshold | 0.9861————0.3290 | Soluble |
| Cell-Penetrating Potential | score threshold | 0.7147————0.5028 | Cell-Penetrating |
| Toxicity Risk | score threshold | 0.3804————0.4900 | Non-Toxic |
| PAMPA Passive Membrane Permeability | predicted value | -7.425 | PAMPA prediction: lower passive membrane permeability |
| Caco-2 Permeability | predicted value | -5.855 | Caco-2 prediction: higher cell-model permeability |
| Half-Life Model Output | model output | 0.8954 | Model output only, not in-vivo half-life |